The final stage of Paris-Nice follows a familiar recipe—starting and finishing in the Côte d'Azur metropolis, with a detour into the hills overlooking the city. The Col de la Porte, Côte de ...

NICE has issued a final “no” to Bristol-Myers Squibb’s oral MS drug Zeposia (ozanimod), in a decision that prevents access for patients in England and Wales.